Dipsacoside B CAS: 33289-85-9

CAS NO: 33289-85-9
Dipsacoside B
Chemical Name: dipsacoside B
Molecular Formula: C53H86O22
Formula Weight: 1075.24
CAS No.: 33289-85-9
Description Review
Description

Dipsacoside B is a natural compound found in the root extract of Dipsacus asperoides, commonly known as Xu Duan in traditional Chinese medicine. It has gained attention for its potential health benefits, particularly in the areas of bone health and anti-inflammatory effects. Dipsacoside B exhibits several biological activities that may contribute to its therapeutic properties.

Chemical name:

β-D-glucopyranoside, (3β,6α,23E)-25-oxocholesta-5,23-dien-3-yl

Molecular formula:

C34H52O7

Formula weight:

580.77 g/mol

CAS No:

33289-85-9

Top ten keywords from Google and Synonyms:

  1. Dipsacoside B
  2. Dipsacus asperoides
  3. Bone health
  4. Anti-inflammatory
  5. Traditional Chinese medicine
  6. Osteoporosis
  7. Cholesterol-lowering
  8. Immune modulation
  9. Herbal medicine
  10. Phytochemistry

Health benefits of this product:

Dipsacoside B has shown potential health benefits in the areas of bone health and anti-inflammatory effects. Studies have found that Dipsacoside B can enhance bone formation and inhibit bone resorption, making it a potential therapy for osteoporosis. Additionally, Dipsacoside B exhibits anti-inflammatory properties, reducing inflammation in the body and potentially preventing chronic diseases.

Potential effects:

Dipsacoside B has several potential effects on the body. One of the primary mechanisms is through its role in bone health, enhancing bone formation while inhibiting bone resorption. Dipsacoside B also exhibits anti-inflammatory properties by inhibiting the expression of pro-inflammatory cytokines. Furthermore, Dipsacoside B has been found to exhibit immune modulatory effects, enhancing the activity of immune cells and potentially preventing infections and autoimmune diseases.

Product mechanism:

Dipsacoside B works by supporting several biological processes in the body, including bone metabolism, immune modulation, and anti-inflammatory effects. The compound enhances bone formation and inhibits bone resorption, promoting bone health and potentially preventing osteoporosis. Additionally, Dipsacoside B exhibits anti-inflammatory properties by inhibiting the expression of pro-inflammatory cytokines. Moreover, Dipsacoside B has been found to modulate the immune system, enhancing the activity of immune cells and potentially preventing infections and autoimmune diseases.

Safety:

Dipsacoside B is generally considered safe and well-tolerated. However, further research is needed to determine the safety and efficacy of Dipsacoside B in humans.

Side effects:

Currently, there are no reported side effects associated with the use of Dipsacoside B.

Dosing information:

There are currently no established guidelines for the dosing of Dipsacoside B in humans. Doses used in preclinical studies have ranged from 5 mg/kg to 100 mg/kg. Further research is needed to determine the optimal dosing regimen for Dipsacoside B in humans.

Conclusion:

Dipsacoside B is a natural compound with potential health benefits, particularly in the areas of bone health and anti-inflammatory effects. The compound plays an important role in bone metabolism and modulates the immune system, potentially preventing chronic diseases such as osteoporosis and autoimmune diseases. While Dipsacoside B shows promise as a therapeutic agent, further research is needed to fully understand its mechanisms of action and potential benefits in humans. Nonetheless, Dipsacoside B remains a promising candidate for the development of novel therapeutics in the future.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code